Literature DB >> 23645641

Neuropsychiatric side effects of cyclobenzaprine.

David Shprecher1, Colgan T Sloan, Benson Sederholm.   

Abstract

Cyclobenzaprine is commonly used as a muscle relaxant and analgesic. Given its tricyclic properties, serotonin syndrome is a potential side effect of this drug. We report an unusual case of a patient who experienced symptoms of delirium and hyperkinetic movement disorders shortly after initiating treatment with cyclobenzaprine and oxycodone. Symptoms resolved within 48 h of discontinuing cyclobenzaprine. This case serves to remind clinicians to monitor for serotonin syndrome when initiating cyclobenzaprine, and when adding opiate or antidepressant medications to the regimen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23645641      PMCID: PMC3669814          DOI: 10.1136/bcr-2013-008997

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  First episode psychosis following cyclobenzaprine use.

Authors:  B A O'Neil; G A Knudson; S M Bhaskara
Journal:  Can J Psychiatry       Date:  2000-10       Impact factor: 4.356

2.  Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity?

Authors:  P Ken Gillman
Journal:  Am J Emerg Med       Date:  2009-05       Impact factor: 2.469

3.  Psychosis following cyclobenzaprine use.

Authors:  A R Beeber; J M Manring
Journal:  J Clin Psychiatry       Date:  1983-04       Impact factor: 4.384

Review 4.  Five-year multicenter retrospective review of cyclobenzaprine toxicity.

Authors:  H A Spiller; M L Winter; K V Mann; D J Borys; S Muir; E P Krenzelok
Journal:  J Emerg Med       Date:  1995 Nov-Dec       Impact factor: 1.484

5.  Torticollis under cyclobenzaprine.

Authors:  Reinhard Reuss; Iris Reuter; Marek Jauss; Falko Fischer; Silke C Muller; Erwin Stolz
Journal:  Pharmacology       Date:  2009-07-08       Impact factor: 2.547

6.  Cyclobenzaprine overdosage.

Authors:  C H Linden; J C Mitchiner; R D Lindzon; B H Rumack
Journal:  J Toxicol Clin Toxicol       Date:  1983-05
  6 in total
  2 in total

1.  Induction of Psychosis by Cyclobenzaprine.

Authors:  Johan Y Cohen; Amélie Guilbault
Journal:  Psychopharmacol Bull       Date:  2018-06-20

Review 2.  Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice.

Authors:  Shawniqua Williams Roberson; Mayur B Patel; Wojciech Dabrowski; E Wesley Ely; Cezary Pakulski; Katarzyna Kotfis
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.